LIGAND PHARMACEUTICALS INC
LGNDZN/A
NASDAQBiotechnology🇺🇸North America
Drugs in Pipeline
3
Phase 3 Programs
1
Upcoming Catalysts
1
Next Catalyst
Nov 23, 2026
22wMarket Overview
Stock performance and key metrics
LGNDZ News
Catalyst Timeline
1 upcoming, 0 past
Drug Pipeline
lasofoxifene
Osteoporosis
Aplindore
Restless Legs Syndrome
Bexarotene
Sarcoma, Kaposi
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
lasofoxifene | Phase 3 | Osteoporosis | - | - |
Aplindore | Phase 2 | Restless Legs Syndrome | - | - |
Bexarotene | Phase 2 | Sarcoma, Kaposi | - | - |
Catalyst Verdict
Market-Implied Move
Regulatory Approvals
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply